BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15713996)

  • 1. S100A4 expression is an early event of papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Oncology; 2004; 67(5-6):397-402. PubMed ID: 15713996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
    Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
    Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.
    Jendrzejewski J; Thomas A; Liyanarachchi S; Eiterman A; Tomsic J; He H; Radomska HS; Li W; Nagy R; Sworczak K; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1370-7. PubMed ID: 26274343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.
    Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM
    J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-100 protein is a differentiation marker in thyroid carcinoma of follicular cell origin: an immunohistochemical study.
    Nishimura R; Yokose T; Mukai K
    Pathol Int; 1997 Oct; 47(10):673-9. PubMed ID: 9361100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer.
    Davies BR; O'Donnell M; Durkan GC; Rudland PS; Barraclough R; Neal DE; Mellon JK
    J Pathol; 2002 Mar; 196(3):292-9. PubMed ID: 11857492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid.
    Min HS; Choe G; Kim SW; Park YJ; Park DJ; Youn YK; Park SH; Cho BY; Park SY
    Mod Pathol; 2008 Jun; 21(6):748-55. PubMed ID: 18360353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
    Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
    J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of acidic and basic fibroblast growth factors in human benign and malignant thyroid lesions.
    Kodama M; Daa T; Kashima K; Yokoyama S; Nakayama I; Noguchi S
    Jpn J Clin Oncol; 1994 Apr; 24(2):66-73. PubMed ID: 7512670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
    Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
    Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
    Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
    Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular, papillary, and "hybrid" carcinomas of the thyroid.
    Castro P; Fonseca E; Magalhães J; Sobrinho-Simões M
    Endocr Pathol; 2002; 13(4):313-20. PubMed ID: 12665649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of E-cadherin in thyroid neoplastic tissues and its correlation with malignant and metastatic potential].
    Naitoh A; Kobayashi S; Iwase H; Kuzushima T
    Nihon Rinsho; 1995 Jul; 53(7):1619-22. PubMed ID: 7629998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of S100A4 expression with invasion and metastasis in oral squamous cell carcinoma.
    Moriyama-Kita M; Endo Y; Yonemura Y; Heizmann CW; Schäfer BW; Sasaki T; Yamamoto E
    Oral Oncol; 2004 May; 40(5):496-500. PubMed ID: 15006621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma.
    Ito Y; Arai K; Nozawa R; Yoshida H; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Kuma K; Miyauchi A
    Anticancer Res; 2007; 27(4C):2679-83. PubMed ID: 17695432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma.
    Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
    Pathol Res Pract; 2003; 199(2):79-83. PubMed ID: 12747469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.
    de Souza Meyer EL; Dora JM; Wagner MS; Maia AL
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.